Related Experiment Video
Updated: May 8, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells
Hung Pham1, C Ekaterina Rodriguez, Graham W Donald
1Department of Surgery, UCLA Center of Excellence in Pancreatic Diseases, UCLA David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA 90095, United States; Department of Medicine, Veterans Affair Greater Los Angeles Healthcare System, Los Angeles, CA 90073, United States.
Abstract:
Small non-coding RNAs, microRNAs (miRNA), inhibit the translation or accelerate the degradation of message RNA (mRNA) by targeting the 3'-untranslated region (3'-UTR) in regulating growth and survival through gene suppression. Deregulated miRNA expression contributes to disease progression in several cancers types, including pancreatic cancers (PaCa). PaCa tissues and cells exhibit decreased miRNA, elevated cyclooxygenase (COX)-2 and increased prostaglandin E2 (PGE2) resulting in increased cancer growth and metastases. Human PaCa cell lines were used to demonstrate that restoration of miRNA-143 (miR-143) regulates COX-2 and inhibits cell proliferation. miR-143 were detected at fold levels of 0.41 ± 0.06 in AsPC-1, 0.20 ± 0.05 in Capan-2 and 0.10 ± 0.02 in MIA PaCa-2. miR-143 was not detected in BxPC-3, HPAF-II and Panc-1 which correlated with elevated mitogen-activated kinase (MAPK) and MAPK kinase (MEK) activation. Treatment with 10 μM of MEK inhibitor U0126 or PD98059 increased miR-143, respectively, by 187 ± 18 and 152 ± 26-fold in BxPC-3 and 182 ± 7 and 136 ± 9-fold in HPAF-II. miR-143 transfection diminished COX-2 mRNA stability at 60 min by 2.6 ± 0.3-fold in BxPC-3 and 2.5 ± 0.2-fold in HPAF-II. COX-2 expression and cellular proliferation in BxPC-3 and HPAF-II inversely correlated with increasing miR-143. PGE2 levels decreased by 39.3 ± 5.0% in BxPC-3 and 48.0 ± 3.0% in HPAF-II transfected with miR-143. Restoration of miR-143 in PaCa cells suppressed of COX-2, PGE2, cellular proliferation and MEK/MAPK activation, implicating this pathway in regulating miR-143 expression.
Insights
Restoring microRNA-143 (miR-143) in pancreatic cancer cells suppresses tumor growth by inhibiting cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2). This study reveals miR-143 as a key regulator in pancreatic cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting messenger RNAs (mRNAs).
- Dysregulated miRNA expression is implicated in various cancers, including pancreatic cancer (PaCa).
- PaCa is characterized by decreased miRNA, elevated cyclooxygenase-2 (COX-2), and increased prostaglandin E2 (PGE2), promoting tumor growth and metastasis.
Purpose of the Study:
- To investigate the role of miRNA-143 (miR-143) in regulating COX-2 and cell proliferation in pancreatic cancer.
- To explore the relationship between miR-143, COX-2, PGE2, and MEK/MAPK signaling in PaCa.
Main Methods:
- Utilized human PaCa cell lines to assess miR-143 levels and its correlation with COX-2, PGE2, and MEK/MAPK activation.
- Administered MEK inhibitors (U0126, PD98059) to observe effects on miR-143 expression.
- Performed miR-143 transfection to evaluate its impact on COX-2 mRNA stability, COX-2 expression, cell proliferation, and PGE2 levels.
Main Results:
- Restoration of miR-143 in PaCa cells significantly inhibited cell proliferation and decreased COX-2 and PGE2 levels.
- miR-143 transfection reduced COX-2 mRNA stability and suppressed MEK/MAPK activation.
- Low miR-143 levels correlated with elevated MEK/MAPK activation in specific PaCa cell lines.
Conclusions:
- Restoring miR-143 expression in pancreatic cancer cells effectively suppresses tumor growth, proliferation, and metastasis.
- miR-143 acts as a tumor suppressor by downregulating COX-2, PGE2, and MEK/MAPK signaling pathways.
- These findings highlight miR-143 as a potential therapeutic target for pancreatic cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

